Repare Therapeutics Inc (RPTX)

Ticker: RPTX Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Repare Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Forte, Steve Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
491.71
Quantity 14,828 -18.5%
Value US$1,052,980
Alves, Sandra Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
485.74
Quantity 23,568 +32.1%
Value US$1,874,115
1.5
Zinda, Michael Senior Officer of Issuer Officer
Transaction date
Sale
Price
47.34
Quantity 79,583 +49.3%
Value US$4,345,610
2.2
SEGAL, Lloyd M. Senior Officer of Issuer Officer
Transaction date
Sale
Price
1.14
Quantity 21,179 -32.2%
Value US$24,144
1.5
Koehler, Maria Senior Officer of Issuer Officer
Transaction date
Sale
Price
1.14
Quantity 3,596 -1.7%
Value US$4,099
1.5
Herman, Philip Senior Officer of Issuer Officer
Transaction date
Sale
Price
1.14
Quantity 3,799 -25.9%
Value US$4,331
1.5
Bélanger, Daniel Senior Officer of Issuer Officer
Transaction date
Sale
Price
1.14
Quantity 1,787 -21.2%
Value US$2,037
2.2
Segal Lloyd Mitchell PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
1.14
Quantity 21,179 -14.5%
Value US$24,144
1.5
Forte Steve EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
1.14
Quantity 6,884 -11.2%
Value US$7,848
1.5
Koehler Maria EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
1.14
Quantity 3,596 -1.6%
Value US$4,099
2.7
Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
1.14
Quantity 5,611 -6.5%
Value US$6,397
2.2
SEGAL, Lloyd M. Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
1.08
Quantity 2,000 +8.2%
Value US$2,160
Forte, Steve Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
1.08
Quantity 2,000 +13.1%
Value US$2,160
Black, Cameron Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
1.08
Quantity 2,000 +7.4%
Value US$2,160
2.2
SEGAL, Lloyd M. Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
2.55
Quantity 895 +3.8%
Value US$2,282
Forte, Steve Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
2.55
Quantity 895 +6.2%
Value US$2,282
Black, Cameron Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
2.55
Quantity 1,268 +5.0%
Value US$3,233
2.2
Segal Lloyd Mitchell PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
4.63
Quantity 2,491 -2.3%
Value US$11,533
2.7
Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
4.66
Quantity 410 -0.6%
Value US$1,911
1.5
Forte Steve EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
4.61
Quantity 789 -1.7%
Value US$3,637
1.5
Koehler Maria EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
4.66
Quantity 300 -0.1%
Value US$1,398
2.2
Segal Lloyd Mitchell PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
4.62
Quantity 2,650 -2.4%
Value US$12,243
2.7
Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
4.64
Quantity 450 -0.6%
Value US$2,088
1.5
Forte Steve EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
4.62
Quantity 825 -1.8%
Value US$3,812
1.5
Koehler Maria EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
4.64
Quantity 500 -0.2%
Value US$2,320
1.5
Zinda, Michael Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.64
Quantity 450 -1.1%
Value US$2,088
Seth, Kim Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.64
Quantity 305 -1.1%
Value US$1,415
Seth, Kim Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.65
Quantity 900 -3.2%
Value US$4,185
2.2
SEGAL, Lloyd M. Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.62
Quantity 2,650 -10.1%
Value US$12,243
1.5
Koehler, Maria Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.64
Quantity 500 -0.2%
Value US$2,320
1.5
Herman, Philip Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.65
Quantity 500 -10.8%
Value US$2,325
Forte, Steve Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.62
Quantity 825 -6.0%
Value US$3,812
Black, Cameron Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.62
Quantity 462 -1.9%
Value US$2,134
1.5
Zinda, Michael Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.62
Quantity 450 -1.1%
Value US$2,079
Seth, Kim Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.60
Quantity 305 -1.1%
Value US$1,403
Seth, Kim Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.61
Quantity 900 -3.1%
Value US$4,149
2.2
SEGAL, Lloyd M. Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.63
Quantity 2,650 -9.1%
Value US$12,270
1.5
Koehler, Maria Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.62
Quantity 500 -0.2%
Value US$2,310
1.5
Herman, Philip Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.62
Quantity 500 -9.8%
Value US$2,310
Forte, Steve Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.62
Quantity 825 -5.6%
Value US$3,812
Black, Cameron Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.62
Quantity 470 -1.9%
Value US$2,171
2.2
Segal Lloyd Mitchell PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
4.63
Quantity 2,650 -3.1%
Value US$12,270
2.7
Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
4.62
Quantity 450 -0.6%
Value US$2,079
1.5
Koehler Maria EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
4.62
Quantity 500 -0.2%
Value US$2,310
1.5
Forte Steve EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
4.62
Quantity 825 -1.9%
Value US$3,812
1.5
Zinda, Michael Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.61
Quantity 450 -1.0%
Value US$2,074
Seth, Kim Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.60
Quantity 305 -1.0%
Value US$1,403
Seth, Kim Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.61
Quantity 900 -3.0%
Value US$4,149
2.2
SEGAL, Lloyd M. Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.64
Quantity 2,650 -8.4%
Value US$12,296
1.5
Koehler, Maria Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.60
Quantity 500 -0.2%
Value US$2,300
1.5
Herman, Philip Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.61
Quantity 500 -8.9%
Value US$2,305
Forte, Steve Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.60
Quantity 825 -5.3%
Value US$3,795
Black, Cameron Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.62
Quantity 470 -1.9%
Value US$2,171
2.2
Segal Lloyd Mitchell PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
4.64
Quantity 2,650 -3.0%
Value US$12,296
2.7
Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
4.61
Quantity 450 -0.6%
Value US$2,074
1.5
Koehler Maria EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
4.60
Quantity 500 -0.2%
Value US$2,300
1.5
Forte Steve EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
4.60
Quantity 825 -1.9%
Value US$3,795
2.2
Segal Lloyd Mitchell Officer Officer
Transaction date
Proposed sale
Price
4.84
Quantity 99,466
Value US$481,415
1.5
Zinda, Michael Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.78
Quantity 450 -1.0%
Value US$2,151
Seth, Kim Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.79
Quantity 305 -1.0%
Value US$1,461
Seth, Kim Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.78
Quantity 900 -2.9%
Value US$4,302
2.2
SEGAL, Lloyd M. Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.79
Quantity 2,650 -7.7%
Value US$12,694
1.5
Koehler, Maria Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.78
Quantity 500 -0.2%
Value US$2,390
1.5
Herman, Philip Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.79
Quantity 500 -8.2%
Value US$2,395
Forte, Steve Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.79
Quantity 825 -5.1%
Value US$3,952
Black, Cameron Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
4.79
Quantity 470 -1.9%
Value US$2,251
1.5
Forte Steve Officer Officer
Transaction date
Proposed sale
Price
4.89
Quantity 4,089
Value US$20,000
2.2
Segal Lloyd Mitchell PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
4.79
Quantity 2,650 -2.9%
Value US$12,694
2.7
Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
4.78
Quantity 450 -0.6%
Value US$2,151
1.5
Koehler Maria EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
4.78
Quantity 500 -0.2%
Value US$2,390
1.5
Forte Steve EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
4.79
Quantity 825 -1.8%
Value US$3,952
2.7
MICHAEL ZINDA Officer Officer
Transaction date
Proposed sale
Price
4.89
Quantity 2,210
Value US$10,807
1.5
MARIA KOEHLER Officer Officer
Transaction date
Proposed sale
Price
4.89
Quantity 2,300
Value US$11,247
2.2
Segal Lloyd Mitchell Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.76
Quantity 13,091
Value US$62,313
2.2
SEGAL, Lloyd M. Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
5.91
Quantity 2,000 +32.6%
Value US$11,820
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-11-17 2025-08-15 PP Planned purchase

Senior Officer of Issuer

Officer
14,828 -18.5%
491.71
US$1,052,980
14,828 -18.5% 491.71 US$1,052,980
2025-11-17 2025-08-15 PP Planned purchase

Senior Officer of Issuer

Officer
23,568 +32.1%
485.74
US$1,874,115
23,568 +32.1% 485.74 US$1,874,115
2025-03-14 2025-03-13 S Sale

Senior Officer of Issuer

Officer
79,583 +49.3%
47.34
US$4,345,610
79,583 +49.3% 47.34 US$4,345,610
2025-03-14 2025-03-13 S Sale

Senior Officer of Issuer

Officer
21,179 -32.2%
1.14
US$24,144
21,179 -32.2% 1.14 US$24,144
2025-03-14 2025-03-13 S Sale

Senior Officer of Issuer

Officer
3,596 -1.7%
1.14
US$4,099
3,596 -1.7% 1.14 US$4,099
2025-03-14 2025-03-13 S Sale

Senior Officer of Issuer

Officer
3,799 -25.9%
1.14
US$4,331
3,799 -25.9% 1.14 US$4,331
2025-03-14 2025-03-13 S Sale

Senior Officer of Issuer

Officer
1,787 -21.2%
1.14
US$2,037
1,787 -21.2% 1.14 US$2,037
2025-03-14 2025-03-12 S Sale

PRESIDENT AND CEO

Executive Director
21,179 -14.5%
1.14
US$24,144
21,179 -14.5% 1.14 US$24,144
2025-03-14 2025-03-12 S Sale

EVP, CHIEF FINANCIAL OFFICER

Officer
6,884 -11.2%
1.14
US$7,848
6,884 -11.2% 1.14 US$7,848
2025-03-14 2025-03-12 S Sale

EVP, CHIEF MEDICAL OFFICER

Officer
3,596 -1.6%
1.14
US$4,099
3,596 -1.6% 1.14 US$4,099
2025-03-14 2025-03-12 S Sale

EVP, CHIEF SCIENTIFIC OFFICER

Officer
5,611 -6.5%
1.14
US$6,397
5,611 -6.5% 1.14 US$6,397
2025-03-07 2025-02-15 PP Planned purchase

Senior Officer of Issuer

Officer
2,000 +8.2%
1.08
US$2,160
2,000 +8.2% 1.08 US$2,160
2025-03-07 2025-02-15 PP Planned purchase

Senior Officer of Issuer

Officer
2,000 +13.1%
1.08
US$2,160
2,000 +13.1% 1.08 US$2,160
2025-03-07 2025-02-15 PP Planned purchase

Senior Officer of Issuer

Officer
2,000 +7.4%
1.08
US$2,160
2,000 +7.4% 1.08 US$2,160
2025-03-07 2024-08-15 PP Planned purchase

Senior Officer of Issuer

Officer
895 +3.8%
2.55
US$2,282
895 +3.8% 2.55 US$2,282
2025-03-07 2024-08-15 PP Planned purchase

Senior Officer of Issuer

Officer
895 +6.2%
2.55
US$2,282
895 +6.2% 2.55 US$2,282
2025-03-07 2024-08-15 PP Planned purchase

Senior Officer of Issuer

Officer
1,268 +5.0%
2.55
US$3,233
1,268 +5.0% 2.55 US$3,233
2024-04-01 2024-04-01 PlS Planned sale

PRESIDENT AND CEO

Executive Director
2,491 -2.3%
4.63
US$11,533
2,491 -2.3% 4.63 US$11,533
2024-04-01 2024-04-01 PlS Planned sale

EVP, CHIEF SCIENTIFIC OFFICER

Officer
410 -0.6%
4.66
US$1,911
410 -0.6% 4.66 US$1,911
2024-04-01 2024-04-01 PlS Planned sale

EVP, CHIEF FINANCIAL OFFICER

Officer
789 -1.7%
4.61
US$3,637
789 -1.7% 4.61 US$3,637
2024-04-01 2024-04-01 PlS Planned sale

EVP, CHIEF MEDICAL OFFICER

Officer
300 -0.1%
4.66
US$1,398
300 -0.1% 4.66 US$1,398
2024-04-01 2024-03-28 PlS Planned sale

PRESIDENT AND CEO

Executive Director
2,650 -2.4%
4.62
US$12,243
2,650 -2.4% 4.62 US$12,243
2024-04-01 2024-03-28 PlS Planned sale

EVP, CHIEF SCIENTIFIC OFFICER

Officer
450 -0.6%
4.64
US$2,088
450 -0.6% 4.64 US$2,088
2024-04-01 2024-03-28 PlS Planned sale

EVP, CHIEF FINANCIAL OFFICER

Officer
825 -1.8%
4.62
US$3,812
825 -1.8% 4.62 US$3,812
2024-04-01 2024-03-28 PlS Planned sale

EVP, CHIEF MEDICAL OFFICER

Officer
500 -0.2%
4.64
US$2,320
500 -0.2% 4.64 US$2,320
2024-03-28 2024-03-28 PlS Planned sale

Senior Officer of Issuer

Officer
450 -1.1%
4.64
US$2,088
450 -1.1% 4.64 US$2,088
2024-03-28 2024-03-28 PlS Planned sale

Senior Officer of Issuer

Officer
305 -1.1%
4.64
US$1,415
305 -1.1% 4.64 US$1,415
2024-03-28 2024-03-28 PlS Planned sale

Senior Officer of Issuer

Officer
900 -3.2%
4.65
US$4,185
900 -3.2% 4.65 US$4,185
2024-03-28 2024-03-28 PlS Planned sale

Senior Officer of Issuer

Officer
2,650 -10.1%
4.62
US$12,243
2,650 -10.1% 4.62 US$12,243
2024-03-28 2024-03-28 PlS Planned sale

Senior Officer of Issuer

Officer
500 -0.2%
4.64
US$2,320
500 -0.2% 4.64 US$2,320
2024-03-28 2024-03-28 PlS Planned sale

Senior Officer of Issuer

Officer
500 -10.8%
4.65
US$2,325
500 -10.8% 4.65 US$2,325
2024-03-28 2024-03-28 PlS Planned sale

Senior Officer of Issuer

Officer
825 -6.0%
4.62
US$3,812
825 -6.0% 4.62 US$3,812
2024-03-28 2024-03-28 PlS Planned sale

Senior Officer of Issuer

Officer
462 -1.9%
4.62
US$2,134
462 -1.9% 4.62 US$2,134
2024-03-28 2024-03-27 PlS Planned sale

Senior Officer of Issuer

Officer
450 -1.1%
4.62
US$2,079
450 -1.1% 4.62 US$2,079
2024-03-28 2024-03-27 PlS Planned sale

Senior Officer of Issuer

Officer
305 -1.1%
4.60
US$1,403
305 -1.1% 4.60 US$1,403
2024-03-28 2024-03-27 PlS Planned sale

Senior Officer of Issuer

Officer
900 -3.1%
4.61
US$4,149
900 -3.1% 4.61 US$4,149
2024-03-28 2024-03-27 PlS Planned sale

Senior Officer of Issuer

Officer
2,650 -9.1%
4.63
US$12,270
2,650 -9.1% 4.63 US$12,270
2024-03-28 2024-03-27 PlS Planned sale

Senior Officer of Issuer

Officer
500 -0.2%
4.62
US$2,310
500 -0.2% 4.62 US$2,310
2024-03-28 2024-03-27 PlS Planned sale

Senior Officer of Issuer

Officer
500 -9.8%
4.62
US$2,310
500 -9.8% 4.62 US$2,310
2024-03-28 2024-03-27 PlS Planned sale

Senior Officer of Issuer

Officer
825 -5.6%
4.62
US$3,812
825 -5.6% 4.62 US$3,812
2024-03-28 2024-03-27 PlS Planned sale

Senior Officer of Issuer

Officer
470 -1.9%
4.62
US$2,171
470 -1.9% 4.62 US$2,171
2024-03-27 2024-03-27 PlS Planned sale

PRESIDENT AND CEO

Executive Director
2,650 -3.1%
4.63
US$12,270
2,650 -3.1% 4.63 US$12,270
2024-03-27 2024-03-27 PlS Planned sale

EVP, CHIEF SCIENTIFIC OFFICER

Officer
450 -0.6%
4.62
US$2,079
450 -0.6% 4.62 US$2,079
2024-03-27 2024-03-27 PlS Planned sale

EVP, CHIEF MEDICAL OFFICER

Officer
500 -0.2%
4.62
US$2,310
500 -0.2% 4.62 US$2,310
2024-03-27 2024-03-27 PlS Planned sale

EVP, CHIEF FINANCIAL OFFICER

Officer
825 -1.9%
4.62
US$3,812
825 -1.9% 4.62 US$3,812
2024-03-28 2024-03-26 PlS Planned sale

Senior Officer of Issuer

Officer
450 -1.0%
4.61
US$2,074
450 -1.0% 4.61 US$2,074
2024-03-28 2024-03-26 PlS Planned sale

Senior Officer of Issuer

Officer
305 -1.0%
4.60
US$1,403
305 -1.0% 4.60 US$1,403
2024-03-28 2024-03-26 PlS Planned sale

Senior Officer of Issuer

Officer
900 -3.0%
4.61
US$4,149
900 -3.0% 4.61 US$4,149
2024-03-28 2024-03-26 PlS Planned sale

Senior Officer of Issuer

Officer
2,650 -8.4%
4.64
US$12,296
2,650 -8.4% 4.64 US$12,296
2024-03-28 2024-03-26 PlS Planned sale

Senior Officer of Issuer

Officer
500 -0.2%
4.60
US$2,300
500 -0.2% 4.60 US$2,300
2024-03-28 2024-03-26 PlS Planned sale

Senior Officer of Issuer

Officer
500 -8.9%
4.61
US$2,305
500 -8.9% 4.61 US$2,305
2024-03-28 2024-03-26 PlS Planned sale

Senior Officer of Issuer

Officer
825 -5.3%
4.60
US$3,795
825 -5.3% 4.60 US$3,795
2024-03-28 2024-03-26 PlS Planned sale

Senior Officer of Issuer

Officer
470 -1.9%
4.62
US$2,171
470 -1.9% 4.62 US$2,171
2024-03-27 2024-03-26 PlS Planned sale

PRESIDENT AND CEO

Executive Director
2,650 -3.0%
4.64
US$12,296
2,650 -3.0% 4.64 US$12,296
2024-03-27 2024-03-26 PlS Planned sale

EVP, CHIEF SCIENTIFIC OFFICER

Officer
450 -0.6%
4.61
US$2,074
450 -0.6% 4.61 US$2,074
2024-03-27 2024-03-26 PlS Planned sale

EVP, CHIEF MEDICAL OFFICER

Officer
500 -0.2%
4.60
US$2,300
500 -0.2% 4.60 US$2,300
2024-03-27 2024-03-26 PlS Planned sale

EVP, CHIEF FINANCIAL OFFICER

Officer
825 -1.9%
4.60
US$3,795
825 -1.9% 4.60 US$3,795
2024-03-26 2024-03-26 PrS Proposed sale

Officer

Officer
99,466
4.84
US$481,415
99,466 4.84 US$481,415
2024-03-28 2024-03-25 PlS Planned sale

Senior Officer of Issuer

Officer
450 -1.0%
4.78
US$2,151
450 -1.0% 4.78 US$2,151
2024-03-28 2024-03-25 PlS Planned sale

Senior Officer of Issuer

Officer
305 -1.0%
4.79
US$1,461
305 -1.0% 4.79 US$1,461
2024-03-28 2024-03-25 PlS Planned sale

Senior Officer of Issuer

Officer
900 -2.9%
4.78
US$4,302
900 -2.9% 4.78 US$4,302
2024-03-28 2024-03-25 PlS Planned sale

Senior Officer of Issuer

Officer
2,650 -7.7%
4.79
US$12,694
2,650 -7.7% 4.79 US$12,694
2024-03-28 2024-03-25 PlS Planned sale

Senior Officer of Issuer

Officer
500 -0.2%
4.78
US$2,390
500 -0.2% 4.78 US$2,390
2024-03-28 2024-03-25 PlS Planned sale

Senior Officer of Issuer

Officer
500 -8.2%
4.79
US$2,395
500 -8.2% 4.79 US$2,395
2024-03-28 2024-03-25 PlS Planned sale

Senior Officer of Issuer

Officer
825 -5.1%
4.79
US$3,952
825 -5.1% 4.79 US$3,952
2024-03-28 2024-03-25 PlS Planned sale

Senior Officer of Issuer

Officer
470 -1.9%
4.79
US$2,251
470 -1.9% 4.79 US$2,251
2024-03-27 2024-03-25 PrS Proposed sale

Officer

Officer
4,089
4.89
US$20,000
4,089 4.89 US$20,000
2024-03-27 2024-03-25 PlS Planned sale

PRESIDENT AND CEO

Executive Director
2,650 -2.9%
4.79
US$12,694
2,650 -2.9% 4.79 US$12,694
2024-03-27 2024-03-25 PlS Planned sale

EVP, CHIEF SCIENTIFIC OFFICER

Officer
450 -0.6%
4.78
US$2,151
450 -0.6% 4.78 US$2,151
2024-03-27 2024-03-25 PlS Planned sale

EVP, CHIEF MEDICAL OFFICER

Officer
500 -0.2%
4.78
US$2,390
500 -0.2% 4.78 US$2,390
2024-03-27 2024-03-25 PlS Planned sale

EVP, CHIEF FINANCIAL OFFICER

Officer
825 -1.8%
4.79
US$3,952
825 -1.8% 4.79 US$3,952
2024-03-25 2024-03-25 PrS Proposed sale

Officer

Officer
2,210
4.89
US$10,807
2,210 4.89 US$10,807
2024-03-25 2024-03-25 PrS Proposed sale

Officer

Officer
2,300
4.89
US$11,247
2,300 4.89 US$11,247
2024-03-25 2024-03-25 PrS Proposed sale

Officer; Director

Executive Director
13,091
4.76
US$62,313
13,091 4.76 US$62,313
2024-03-04 2024-02-15 PP Planned purchase

Senior Officer of Issuer

Officer
2,000 +32.6%
5.91
US$11,820
2,000 +32.6% 5.91 US$11,820

See older Repare Therapeutics Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Repare Therapeutics Inc history with Plus

Billed monthly · Cancel anytime